Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation - Stock Option Activity (Details)

v3.24.1.u1
Stock-Based Compensation - Stock Option Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Exercise Price Per Share [Abstract]    
Exercise Price Per Share, Outstanding, Minimum (per share) $ 0.71 $ 0.71
Exercise Price Per Share, Outstanding, Maximum (dollars per share) 6.74  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]    
Share Based Compensation Shares Authorized Under Stock Option Plans, Granted, Exercise Price Range, Upper Range Limit   $ 10.33
Share Based Compensation Shares Authorized Under Stock Option Plans, Cancelled and Forfeited, Exercise Price Range, Lower Range Limit 0.74  
Share Based Compensation Shares Authorized Under Stock Option Plans, Cancelled and Forfeited, Exercise Price Range, Upper Range Limit $ 10.33  
Tecogen    
Stock Options Outstanding [Roll Forward]    
Beginning (shares) 3,638,122  
Canceled and forfeited (shares) (801,350)  
Ending (shares) 2,836,772 3,638,122
Exercisable (shares) 1,643,022  
Vested and expected to vest (shares) 2,657,710  
Weighted Average Exercise Price [Roll Forward]    
Beginning (usd per share) $ 1.49  
Canceled and forfeited (usd per share) 2.73  
Ending (usd per share) 1.14 $ 1.49
Exercisable (usd per share) 1.28  
Vested and expected to vest (usd per share) $ 1.16  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]    
Outstanding, Aggregate Intrinsic Value   $ 127,811
Vested and expected to vest, Aggregate Intrinsic Value $ 0  
Tecogen | Stock Options    
Weighted Average Exercise Price [Roll Forward]    
Weighted Average Remaining Life 7 years 21 days 6 years 8 months 12 days